Cargando…

Perspective: Industry–patient relationships for the promotion of pharmaceutical agents

Detalles Bibliográficos
Autores principales:	Bryarly, Meredith A., Rubin, Michael A., Stuve, Olaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619335/ https://www.ncbi.nlm.nih.gov/pubmed/37920862 http://dx.doi.org/10.1177/17562864231207560

Ejemplares similares

Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment
por: Manouchehri, Navid, et al.
Publicado: (2021)

Relationship between Doctors’ Prescribing Behavior and Pharmaceutical Promotional Tools: A Pakistani Case
por: ALI, Zaigham, et al.
Publicado: (2015)

Effects of Law Regarding Prevention of Dishonest Solicitation on the Korean Pharmaceutical Industry
por: Yoon, Sung Man
Publicado: (2021)

Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
por: Lu, Jinmiao, et al.
Publicado: (2023)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Looking at CER from the Pharmaceutical Industry Perspective
por: Dubois, Robert W.
Publicado: (2012)

Limb myorhythmia treated with chemodenervation: a case report
por: Saez-Calveras, Nil, et al.
Publicado: (2023)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Changes in the interaction of ophthalmologists and ophthalmic industry during and after COVID-19 lockdown: A perspective
por: Sanjay, Srinivasan, et al.
Publicado: (2020)

Tumefactive demyelination following herbal supplement use: Cause or coincidence?
por: Dubey, D, et al.
Publicado: (2016)

Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry
por: Debon, Aaron, et al.
Publicado: (2023)

Evolving role of pharmaceutical physicians in the industry: Indian perspective
por: Patil, Anant, et al.
Publicado: (2012)

Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective
por: Bansal, Dipika, et al.
Publicado: (2013)

Effect of Mask on Doctor–Patient Relationship during COVID-19: Indian Perspective
por: Banerjee, Sattwika, et al.
Publicado: (2022)

Impacts of international sanctions on Iranian pharmaceutical market
por: Cheraghali, Abdol Majid
Publicado: (2013)

Pharmaceutical practice and selling of drugs during Ramadan
por: Jarrar, YazunB.
Publicado: (2011)

COVID-19 in Nigeria: Is the pharmaceutical sector spared?
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2020)

Colchicine Intolerance: Does the Pharmaceutical Preparation Matter?
por: İlgen, Ufuk, et al.
Publicado: (2021)

The need to develop and sustain a symbiotic relationship between the industry and academia in the field of clinical pharmacology in India
por: Gupta, Sandeep Kumar
Publicado: (2011)

Online Reverse Supply Chain: New Layout to Promote Recycling Industry in China, 2015–2019
por: WU, Di, et al.
Publicado: (2020)

Pharmaceutical companies as the funding sources for continuing medical education
por: Kanchan, Tanuj
Publicado: (2015)

Bayesian Statistical Methods and Their Valuable Applications in the Pharmaceutical Sciences
por: MADADIZADEH, Farzan, et al.
Publicado: (2016)

Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies
por: Sharma, Rohit, et al.
Publicado: (2017)

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)

In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications
por: García, Mauricio A., et al.
Publicado: (2022)

Anti-idiotype antibodies in cancer treatment: the pharmaceutical industry perspective
por: Gómez, Roberto E., et al.
Publicado: (2012)

Public perceptions of physician-pharmaceutical industry relationships and trust in physicians
por: Saito, Sayaka, et al.
Publicado: (2023)

Pharmaceutical waste from hospitals and homes: Need for better strategies
por: Pore, Shraddha M.
Publicado: (2014)

Good pharmacovigilance practice: Need of the hour from pharmaceutical companies
por: Bhati, Neha, et al.
Publicado: (2015)

Emergency response to occupational brucellosis in a pharmaceutical manufacturing enterprise
por: Zhang, Meibian, et al.
Publicado: (2019)

Emergency response to occupational brucellosis in a pharmaceutical manufacturing enterprise
por: Yoshida, Go J.
Publicado: (2019)

Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals
por: Cosentino, Marco, et al.
Publicado: (2021)

The Relationship between Hospital-Based Clinical Pharmacologists and the Pharmaceutical Industry
por: Parsons, R. L.
Publicado: (1979)

GPs’ perceptions of their relationship with the pharmaceutical industry: a qualitative study
por: Larkin, James, et al.
Publicado: (2021)

Industry influence on IAOH
por: Joshi, Tushar Kant
Publicado: (2008)

Agent-Based Modeling: An Innovative Opportunity for Population-Based Oral Health Promotion
por: Roudsari, Maryam Sadeghipour, et al.
Publicado: (2016)

Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity?
por: Drosos, Alexandros A., et al.
Publicado: (2022)

Beyond pharmaceuticals: The untapped potential of homeopathy in the battle against COVID-19
por: de Farias Morais, Gabriel Christian, et al.
Publicado: (2023)

Mendelian randomization applied to pharmaceutical use: the case of metformin and lung cancer
por: Yarmolinsky, James, et al.
Publicado: (2020)

HPLC in the pharmaceutical industry /
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_5am6nus4e5d01afn7sv60dnm95